by Staff Writer, March 25, 2020
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from March 2020.
by Staff Writer, March 17, 2020
In this Expert Insights interview, we sit down with Dr. Uma Sharma, Chief Scientific Officer at MMS Holdings. Dr. Sharma discusses her thoughts surrounding the Circle of Concern and the Circle of Influence, including how it influences the culture at MMS.
by Staff writer
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. February’s news includes coronavirus vaccine development, saving 7 million lives from cancer, and more.
by Aaron Robert, February 7, 2020
The pharmaceutical industry—and healthcare in general—are in constant stages of innovation. According to the International Federation of Pharmaceutical Manufacturers & Associations, the number of new chemical or biological entities launched on the world market stood at 226 from the years 2011 to 2015, a 35 percent increase from the decade prior.
by Staff Writer
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from November 2019.
by Staff Writer
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from October 2019…
Webinar: The Programmers Approach to Real World Data and Using Real World Evidence in Research and Healthcare
by MMS Holdings and MichBio.org
This webinar is intended to help guide individuals towards a better understanding of core concepts and requirements for using real-world data (RWD). Here, we will delve into how one can derive and utilize real-world evidence (RWE) in drug development, from the perspective of a clinical trial programmer/data analyst. We will discuss the potential opportunities that can generate RWD to improve the safety, efficiency, and quality in a clinical paradigm.
Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection of top stories to keep an eye on in September 2019: FDA Developing Guidance on Real-World Data Quality Issues, Officials Say.
By Regina Parott, September 12, 2019
In March 2019, Health Canada created a new transparency requirement. Health Canada’s Public Release of Clinical Information (PRCI) states that their “objective is to make anonymized clinical information in drug submissions and medical device applications publicly available for non-commercial purposes following the completion of Health Canada’s regulatory review process, while adhering to Canada’s Privacy Act”.
By Don McLean, MBA, September 5, 2019
In the pharmaceutical industry, the right talent can often live in a variety of locations. When talking to our colleagues who have the privilege to work from home (WFH), we found that they are happy, productive, and active contributors to the workplace on a daily basis. According to an article on Inc.com, employee attrition decreases by 50 percent for those who work remotely and employees work a true full-shift, compared to those working in the office.